Skip to content
10-Q

Quarterly Report

SPRINGWORKS THERAPEUTICS, INC.

0001773427-24-000033

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 5, 2024 74.39M sh
Shares Diluted Q3 2024 · Sep 30, 2024 74.26M sh
Shares Diluted Q3 2024 · Sep 30, 2024 74.05M sh
Shares Diluted Q3 2024 · Sep 30, 2023 62.52M sh
Shares Diluted Q3 2024 · Sep 30, 2023 62.39M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $7.92M
Stock Repurchased Q3 2024 · Sep 30, 2023 $2.55M
Capex Q3 2024 · Sep 30, 2024 $3.4M
Capex Q3 2024 · Sep 30, 2023 $9.69M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$146.1M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$160.09M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $84.46M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $176.05M
Stockholders Equity Q3 2024 · Sep 30, 2024 $532.58M
Stockholders Equity Q3 2024 · Jun 30, 2024 $556.73M
Stockholders Equity Q3 2024 · Dec 31, 2023 $626.22M
Stockholders Equity Q3 2024 · Sep 30, 2023 $394.9M
Stockholders Equity Q3 2024 · Jun 30, 2023 $451.44M
Stockholders Equity Q3 2024 · Dec 31, 2022 $558.19M
Current Liabilities Q3 2024 · Sep 30, 2024 $70.61M
Current Liabilities Q3 2024 · Dec 31, 2023 $78.17M
Total Liabilities Q3 2024 · Sep 30, 2024 $76.3M
Total Liabilities Q3 2024 · Dec 31, 2023 $99.57M
Current Assets Q3 2024 · Sep 30, 2024 $435.11M
Current Assets Q3 2024 · Dec 31, 2023 $500.91M
Total Assets Q3 2024 · Sep 30, 2024 $608.88M
Total Assets Q3 2024 · Dec 31, 2023 $725.79M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.72
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.44
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.27
Eps Diluted Q3 2024 · Sep 30, 2023 −$3.70
Eps Basic Q3 2024 · Sep 30, 2024 −$0.72
Eps Basic Q3 2024 · Sep 30, 2024 −$2.44
Eps Basic Q3 2024 · Sep 30, 2023 −$1.27
Eps Basic Q3 2024 · Sep 30, 2023 −$3.70
Sga Expense Q3 2024 · Sep 30, 2024 $61.6M
Sga Expense Q3 2024 · Sep 30, 2024 $179.55M
Sga Expense Q3 2024 · Sep 30, 2023 $46.55M
Sga Expense Q3 2024 · Sep 30, 2023 $137.72M
Rd Expense Q3 2024 · Sep 30, 2024 $42.3M
Rd Expense Q3 2024 · Sep 30, 2024 $140.28M
Rd Expense Q3 2024 · Sep 30, 2023 $37.45M
Rd Expense Q3 2024 · Sep 30, 2023 $106.84M
Net Income Q3 2024 · Sep 30, 2024 −$53.53M
Net Income Q3 2024 · Sep 30, 2024 −$180.83M
Net Income Q3 2024 · Sep 30, 2023 −$79.44M
Net Income Q3 2024 · Sep 30, 2023 −$230.78M
Operating Income Q3 2024 · Sep 30, 2024 −$57.94M
Operating Income Q3 2024 · Sep 30, 2024 −$196.79M
Operating Income Q3 2024 · Sep 30, 2023 −$84M
Operating Income Q3 2024 · Sep 30, 2023 −$244.55M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $3.34M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $7M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $0
Cost Of Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2024 $49.3M
Revenue Q3 2024 · Sep 30, 2024 $130.04M
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $0